External Validation of the LabBM Score in Patients With Brain Metastases
Authors:
Open Access
- 1 January 2019
- journal article
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 11 (5) , 321-325
Abstract
Background: The aim of this study was to validate the prognostic impact of the recently introduced three-tiered LabBM score in patients with brain metastases. In contrast to the previous development and validation cohorts, the present cohort did not include patients treated with primary surgery and/or radiosurgery. The score is based on hemoglobin, platelet counts, albumin, C-reactive protein and lactate dehydrogenase. Methods: This was a retrospective single institution analysis. Overall, 167 patients managed with first-line whole-brain radiotherapy (WBRT) were identified from a prospectively maintained database. Results: The LabBM score significantly predicted overall survival (median 4.0, 2.9 and 1.5 months, respectively). Conclusions: The LabBM score is also valid in a patient population that differs from the previously studied cohorts, that is patients who were judged to be better candidates for WBRT than surgery or radiosurgery. As these patients in general represent a less favorable subset, their median survival was shorter than reported in the development cohort (11, 7 and 3 months, respectively). Future studies should examine whether or not combinations of the LabBM and other scores, for example, lung-molGPA and melanoma-molGPA, improve the clinical value of single scores. J Clin Med Res. 2019;11(5):321-325 doi: https://doi.org/10.14740/jocmr3746Keywords
This publication has 17 references indexed in Scilit:
- Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation studyJournal of Neuro-Oncology, 2018
- Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomogramsCritical Reviews in Oncology/Hematology, 2018
- Mechanisms and Therapy for Cancer Metastasis to the BrainFrontiers in Oncology, 2018
- Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain MetastasesIn Vivo, 2018
- Predicting prognosis of short survival time after palliative whole-brain radiotherapyJournal of Radiation Research, 2017
- Estimating Survival in Patients With Lung Cancer and Brain MetastasesJAMA Oncology, 2017
- The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastasesClinical and Translational Oncology, 2017
- Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases—development and validation of the LabBM scoreNeuro-Oncology, 2017
- Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ InvolvementClinical Oncology, 2014
- Identification of prognostic factors in patients with brain metastases: a review of 1292 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999